Sleep Across the Lifespan: Aging, Menopause, and Changing Needs

Sleep Across the Lifespan: Aging, Menopause, and Changing Needs

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers for medical decisions. Never delay seeking medical care based on content you’ve read. If experiencing a medical emergency, seek immediate medical attention.

These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.

In Brief: Sleep changes with age, but not all of those changes are problems. Real aging physiology, including less deep sleep, more fragmentation, and earlier timing, is often blended with modifiable drivers such as apnea, nocturia, pain, and medications. Menopause adds a long window of fragmentation that overlaps a rise in cardiovascular risk. Aging changes the architecture of sleep, but most of the sleep older adults actually suffer from is driven by something specific and addressable. For cardiovascular patients, and especially those on anticoagulation, night-time disruption is a safety issue and not only a matter of comfort.

Sleep changes across adulthood for two reasons that often get blended together. The first is predictable physiology, because the aging brain and circadian system reshape how sleep is built. The second is an accumulation of drivers that arrive with age, including sleep apnea, insomnia physiology, nocturia, pain, mood changes, and medication effects. The goal of good sleep in later life is not to sleep the way you did at twenty-five. It is to recognize which changes are expected and which patterns reflect common, modifiable contributors that carry real cardiovascular and safety consequences.

What Aging Does to Sleep Architecture

Several architectural changes are consistent enough to be considered normal aging. Slow-wave sleep, the deepest stage of non-REM sleep, declines progressively from young adulthood onward (1, 2). Sleep efficiency falls, so older adults spend more of the night awake after first falling asleep (1, 2). Sleep also becomes lighter and more fragmented, and circadian timing tends to shift earlier, which leaves many older adults sleepy earlier and awake before dawn (1, 3).

Other things change less than people assume. The proportion of REM sleep is relatively preserved until very old age, with only a modest decline (1, 2). The value of adequate sleep duration also persists. Whether true sleep need falls with age remains debated, and many older adults still function best with roughly seven to eight hours (2).

Deep non-REM sleep is usually the most autonomically quiet part of the night. With aging there is simply less time in that state and more fragmentation around it (2). This does not prove that losing deep sleep causes cardiovascular disease. It does help explain why sleep can become a more fragile cardiovascular exposure later in life. But the architecture itself is rarely the main problem; what wakes older adults is usually something specific and treatable.

Wearables, Sleep Scores, and Orthosomnia

Consumer wearables are useful for tracking trends, such as bedtime regularity and large deviations from a person’s own baseline. Their stage estimates are less reliable, and deep-sleep scores in particular can be inaccurate (4). Accuracy often worsens when sleep is fragmented, which is exactly the pattern common in older adults (4). A further problem is orthosomnia, an anxiety-driven pursuit of perfect tracked sleep that can worsen sleep through worry and time-in-bed behaviors (5). In a person aged sixty-five to eighty, a low deep-sleep score may simply reflect normal aging physiology graded by an algorithm. Symptoms, daytime function, and safety should remain the primary signals, and the score should be read as an estimate rather than a diagnosis (1, 2, 4, 5).

Where Sleep and Cardiovascular Risk Intersect Across Adulthood

Midlife is often where sleep debt becomes structural. Stress, caregiving, weight gain, and rising rates of hypertension and diabetes converge, and obstructive sleep apnea frequently begins in these years (6). It often goes unrecognized for a long time, which creates an extended runway of intermittent hypoxia, sympathetic surges, and fragmented sleep (6).

Menopause is a distinct sleep transition that overlaps a rise in cardiometabolic risk. Sleep disturbance is very commonly reported during the menopausal transition (7, 8). Vasomotor symptoms such as hot flashes and night sweats drive awakenings and make it harder to fall back asleep (8, 9). Mood vulnerability can worsen sleep independently (8, 9). Obstructive sleep apnea risk also rises with age and after menopause, and women gradually move toward male prevalence across cohorts (6, 10). Two evidence-based treatment lanes come up often with clinicians. Cognitive behavioral therapy for insomnia is effective in peri- and postmenopausal women, including those with vasomotor symptoms (11). Hormone therapy is the most effective treatment for vasomotor symptoms and can improve sleep in symptomatic women, though the risk-benefit balance is individualized (12).

Older adulthood brings genuine physiologic change, including less deep sleep, more fragmentation, and earlier timing. Yet the sleep people actually suffer from is usually driven by a familiar set of repeat offenders (13).

Nocturia: The Most Common and Most Consequential Disruptor

Nocturia is waking during the main sleep period to void, with the intention of returning to sleep (14). It is extremely common with age and is not merely an annoyance. It is associated with an increased risk of falls and, in meta-analysis, a signal toward higher fracture risk (15). For patients on anticoagulants or antiplatelet agents, a night-time fall carries higher consequences, because even minor head trauma can cause traumatic intracranial hemorrhage (16).

Nocturia is also multifactorial, which is why it is worth taking apart. The International Continence Society emphasizes separating phenotypes, because high night-time urine volume, reduced bladder capacity, and sleep-fragmentation-first patterns each have different implications (14). One high-yield subset involves dependent leg edema from venous insufficiency or heart failure physiology. Fluid that pools in the legs during the day returns centrally when a person lies down, raising night-time urine production (17). This broader rostral fluid shift is described across cardiopulmonary and sleep literature, including in heart failure and sleep apnea (17, 18). When nocturia clearly travels with late-day leg swelling, clinicians often discuss reducing dependent edema before bed, and pilot data suggest compression stockings may improve nocturia measures in selected patients (19).

Medications: A Fixable Driver That Is Easy to Miss

New sleep problems in older adults are frequently secondary insomnia, meaning sleep disrupted by a medication’s effect, timing, dose change, interaction, or heightened sensitivity (13). Reviews of sleep in older adults consistently place medication review in the first pass of evaluation (13). Several patterns recur in practice. Sedative-hypnotics and related agents can raise the risk of falls, delirium, and cognitive side effects, and many are flagged as potentially inappropriate in geriatric prescribing guidance (20). Antidepressants can be activating or sedating, and their effect on sleep depends on the agent, class, and dose (21). Corticosteroids are a well-described cause of sleep disturbance and can contribute to insomnia and other neuropsychiatric effects (22). Beta-blockers, particularly lipophilic agents that cross into the brain, have been associated with insomnia and, in pharmacovigilance datasets, nightmares, though a recent meta-analysis judged that evidence inconclusive and agent-dependent (23). The practical clue is timing, because a change soon after a drug was started, stopped, adjusted, or moved later in the day is high-yield (13, 20).

Insomnia, Apnea, and the Mechanical Fragmenters

A common older-adult pattern is spending far longer in bed than the body actually sleeps, sometimes nine or ten hours in bed for six or seven hours of sleep. That habit lowers sleep efficiency and entrenches insomnia physiology, and cognitive behavioral therapy for insomnia is guideline-supported and effective in older adults (24). Obstructive sleep apnea also becomes more common with age and is often under-recognized, because older adults may not report dramatic sleepiness (6). Instead it can surface as normalized fatigue, resistant hypertension, new atrial fibrillation, or cognitive fog. Many awakenings are mechanical rather than primary insomnia, driven by musculoskeletal pain, limited comfortable positions, reflux, or positional breathing (13). Lower urinary tract symptoms add another layer, with prostate-related patterns common in older men and overactive bladder common in older women (14).

Movement and Dream-Enactment Disorders

Two neurologic sleep disorders deserve attention in older adults. Restless legs syndrome becomes more prevalent with age and can be profoundly disruptive to sleep continuity (25). REM sleep behavior disorder, in which a person physically enacts dreams, is also more common with age. It is associated with later neurodegenerative disease risk and is a safety concern for both the patient and the bed partner (26).

How Common Night-Time Complaints Sort Out

Common Assumptions Measured Against the Physiology

The Bottom Line

Aging genuinely reshapes sleep architecture, and menopause is a real sleep transition that overlaps a shift in cardiometabolic risk. Midlife is where chronic sleep restriction and undiagnosed apnea often begin their long cardiovascular footprint. The practical point holds across all of it. Aging changes the architecture of sleep, but most of the sleep older adults actually suffer from is driven by something specific and addressable. Those drivers are usually nocturia, sometimes powered by leg edema and fluid redistribution, along with medication effects, insomnia reinforcement, pain, and under-recognized apnea. For cardiovascular patients, and especially for those on anticoagulation, night-time disruption is not only a matter of quality of life, because it is also safety and risk management (15, 16).

What Comes Next

The final article turns from understanding sleep to protecting it. It builds these threads into a durable system of stable timing, adequate duration, and continuity, with the disorders and safety risks described here treated early rather than late.

Key Terms

Slow-wave sleep (N3): the deepest stage of non-REM sleep, which declines with age (1, 2).

Sleep efficiency: total sleep time divided by time in bed, expressed as a percentage (1, 2).

Circadian advance: a shift toward earlier sleep and wake timing with aging (3).

Orthosomnia: tracking-driven sleep anxiety and perfectionism that can worsen sleep (5).

Nocturia: waking during the main sleep period to void, intending to return to sleep (14).

Rostral fluid shift: the redistribution of dependent fluid centrally when lying down, relevant in heart failure and apnea physiology (17, 18).

References

1. Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255-1273. doi:10.1093/sleep/27.7.1255. PMID: 15586779.
2. Mander BA, Winer JR, Walker MP. Sleep and human aging. Neuron. 2017;94(1):19-36. doi:10.1016/j.neuron.2017.02.004.
3. Duffy JF, Zitting KM, Chinoy ED. Aging and circadian rhythms. Sleep Med Clin. 2015;10(4):423-434. doi:10.1016/j.jsmc.2015.08.002.
4. Ameen MS, Cheung LM, Hauser T, Hahn MA, Schabus M. About the accuracy and problems of consumer devices in the assessment of sleep. Sensors (Basel). 2019;19(19):4160. doi:10.3390/s19194160.
5. Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? J Clin Sleep Med. 2017;13(2):351-354. doi:10.5664/jcsm.6472. PMID: 27855740.
6. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-1239. doi:10.1164/rccm.2109080. PMID: 11991871.
7. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause. 2003;10(1):19-28. doi:10.1097/00042192-200310010-00005. PMID: 12544673.
8. Baker FC, Lampio L, Saaresranta T, Polo-Kantola P. Sleep and sleep disorders in the menopausal transition. Sleep Med Clin. 2018;13(3):443-456. doi:10.1016/j.jsmc.2018.04.011. PMID: 30098758.
9. Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause. 2007;14(5):826-829. doi:10.1097/GME.0b013e3180321a22. PMID: 17486023.
10. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med. 2001;163(3 Pt 1):608-613. doi:10.1164/ajrccm.163.3.9911064. PMID: 11254512.
11. McCurry SM, Guthrie KA, Morin CM, et al. Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial. JAMA Intern Med. 2016;176(7):913-920. doi:10.1001/jamainternmed.2016.1795. PMID: 27213646.
12. The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028. PMID: 35797481.
13. Suzuki K, Miyamoto M, Hirata K. Sleep disorders in the elderly: diagnosis and management. J Gen Fam Med. 2017;18(2):61-71. doi:10.1002/jgf2.27.
14. Everaert K, Hervé F, Bosch R, et al. International Continence Society consensus on the diagnosis and treatment of nocturia. Neurourol Urodyn. 2019;38(2):478-498. doi:10.1002/nau.23939. PMID: 30779378.
15. Pesonen JS, Vernooij RWM, Cartwright R, et al. The impact of nocturia on falls and fractures: a systematic review and meta-analysis. J Urol. 2020;203(4):674-683. doi:10.1097/JU.0000000000000459.
16. Ganetsky M, Lopez G, Coreanu T, et al. Risk of intracranial hemorrhage in ground-level fall with antiplatelet or anticoagulant agents. Acad Emerg Med. 2017;24(10):1258-1266. doi:10.1111/acem.13217. PMID: 28475282.
17. Yumino D, Redolfi S, Ruttanaumpawan P, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation. 2010;121(14):1598-1605. doi:10.1161/CIRCULATIONAHA.109.902452. PMID: 20351237.
18. White LH, Bradley TD. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol. 2013;591(5):1179-1193. doi:10.1113/jphysiol.2012.245159. PMID: 23230237.
19. Kaga K, Yamanishi T, Shibata C, et al. The efficacy of compression stockings on patients with nocturia: a single-arm pilot study. Cureus. 2022;14(8):e28603. doi:10.7759/cureus.28603.
20. By the 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081. doi:10.1111/jgs.18372. PMID: 37139824.
21. Wichniak A, Wierzbicka A, Walęcka M, Jernajczyk W. Effects of antidepressants on sleep. Curr Psychiatry Rep. 2017;19(9):63. doi:10.1007/s11920-017-0816-4. PMID: 28791566.
22. Cole JL. Steroid-induced sleep disturbance and delirium: a focused review for critically ill patients. Fed Pract. 2020;37(6):260-267. PMID: 32669778.
23. Eddin LE, Preyra R, Ahmadi F, et al. β-Blockers and risk of neuropsychiatric disorders: a systematic review and meta-analysis. Br J Clin Pharmacol. 2025;91(2):325-337. doi:10.1111/bcp.16361.
24. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255-262. doi:10.5664/jcsm.8986. PMID: 33164742.
25. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165(11):1286-1292. doi:10.1001/archinte.165.11.1286.
26. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic REM sleep behavior disorder. Neurology. 1996;46(2):388-393. doi:10.1212/WNL.46.2.388.

HeartBuddi • Your heart. Own it.